Interestingly, one study has isolated GFAP expressing cells from blood of grade IV astrocytoma patients and showed that they contain astrocytoma specific mutations, indicating that GFAP positive glioma cells can leave the tumor and enter the bloodstream (Muller et al., 2014). This evidence concerns the gene GFAP and central nervous system cancer.